NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...

Body mass index (BMI) has long been a common tool for estimating a person's relative weight status based on a simple height to weight ratio. It's easy to calculate, widely accessible and often used ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...

A third of the drugs that are currently being trialled are 'repurposed' medications that are already being used to tackle ...

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease. Some 138 treatments are being ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...